Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New transfusion practice and haemostasis.

G Myllylä1

  • 1Finnish Red Cross Blood Transfusion Service, Helsinki.

Acta Anaesthesiologica Scandinavica. Supplementum
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Von Willebrand disease in Finland.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Transfusion thresholds in common elective surgical procedures in Finland.

Vox sanguinis·2000
Same author

The official requirements for platelet concentrates.

Vox sanguinis·1999
Same author

Factors determining quality of plasma.

Vox sanguinis·1998
Same author

Transfusion policies in coronary artery bypass--a nationwide survey in Finland.

Acta anaesthesiologica Scandinavica·1998
Same author

Association of the fatty acid composition of serum phospholipids with hemostatic factors.

Arteriosclerosis, thrombosis, and vascular biology·1997
Same journal

Abstracts from the Scandinavian Society of Anaesthesiologists, 30th Congress, 10-13 June 2009, Odense, Denmark.

Acta anaesthesiologica Scandinavica. Supplementum·2009
Same journal

Abstracts from the 29th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, 5-8 September 2007, Goteborg, Sweden.

Acta anaesthesiologica Scandinavica. Supplementum·2007
Same journal

Abstracts from the 28th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Reykjavik, Iceland.

Acta anaesthesiologica Scandinavica. Supplementum·2005
Same journal

Abstracts from the 27th Congress of The Scandinavian Society of Anaesthesiology and Intensive Care Medicine. August 16-20, 2003, Helsinki, Finland.

Acta anaesthesiologica Scandinavica. Supplementum·2003
Same journal

Abstracts from the 26th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. June 13-17, 2001. Tromso, Norway.

Acta anaesthesiologica Scandinavica. Supplementum·2001
Same journal

The Scandinavian Society of Anaesthesiologists 25th Congress. Aarhus, Denmark, June 9-11, 1999. Abstracts.

Acta anaesthesiologica Scandinavica. Supplementum·1999
See all related articles

Managing bleeding after transfusion and surgery requires understanding multifactorial causes. Specific diagnosis of haemostatic defects, not just dilution, is key for effective treatment, as prophylactic therapies are often insufficient.

Area of Science:

  • Transfusion Medicine
  • Haematology
  • Surgical Complications

Background:

  • Haemostatic deficiency is a common complication after blood transfusion and surgery.
  • Multifactorial mechanisms contribute to bleeding tendencies.
  • Current component therapy protocols often focus on dilution as the primary defect.

Purpose of the Study:

  • To evaluate the effectiveness of current protocols for preventing haemostatic abnormalities.
  • To emphasize the need for specific diagnosis in managing bleeding disorders.
  • To highlight limitations of prophylactic fresh frozen plasma and platelet concentrate use.

Main Methods:

  • Review of existing literature on haemostatic deficiency post-transfusion and surgery.
  • Analysis of component therapy protocols and their underlying assumptions.

Related Experiment Videos

  • Evaluation of the efficacy of prophylactic treatments.

    • Main Results:

    • Prophylactic administration of fresh frozen plasma and platelet concentrates has shown limited effectiveness.
    • The assumption that dilution is the main defect may not always hold true.
    • Current approaches may not adequately address the multifactorial nature of bleeding.

    Conclusions:

    • Effective management of bleeding tendency requires a specific diagnosis of the underlying haemostatic defect.
    • Component therapy protocols need to be tailored based on individual patient diagnostics.
    • Rethinking prophylactic strategies is necessary for improved patient outcomes.